awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37791429-A90D2705-BB4B-4351-94FA-06B10418BDF5
Q37791429-A90D2705-BB4B-4351-94FA-06B10418BDF5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37791429-A90D2705-BB4B-4351-94FA-06B10418BDF5
Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.
P2860
Q37791429-A90D2705-BB4B-4351-94FA-06B10418BDF5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37791429-A90D2705-BB4B-4351-94FA-06B10418BDF5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a65d6ba83e6deb7e546c29ce0521efa3261f6762
P2860
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion